BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 673092)

  • 1. Focal glomerulosclerosis: natural history and treatment. A report of 70 cases.
    Beaufils H; Alphonse JC; Guedon J; Legrain M
    Nephron; 1978; 21(2):75-85. PubMed ID: 673092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of treatment with corticosteroids and indomethacin on proteinuria].
    Michielsen P; Lambert PP
    J Urol Nephrol (Paris); 1967; 73(4):340-55. PubMed ID: 6066085
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug treatment of the chronic idiopathic glomerulopathies.
    Lindeman RD
    Postgrad Med; 1977 Sep; 62(3):135-43. PubMed ID: 302444
    [No Abstract]   [Full Text] [Related]  

  • 4. Focal segmental glomerulosclerosis with idiopathic nephrotic syndrome: three types of clinical response.
    Arbus GS; Poucell S; Bacheyie GS; Baumal R
    J Pediatr; 1982 Jul; 101(1):40-5. PubMed ID: 7045316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meclofenamate treatment of recurrent idiopathic nephrotic syndrome with focal segmental glomerulosclerosis after renal transplantation.
    Torres VE; Velosa JA; Holley KE; Frohnert PP; Zincke H; Sterioff S
    Mayo Clin Proc; 1984 Mar; 59(3):146-52. PubMed ID: 6369011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of treatment of corticosteroid-resistant idiopathic (primary) focal and segmental hyalinosis and sclerosis (focal glomerulosclerosis) with ciclosporin.
    Walker RG; Kincaid-Smith P
    Nephron; 1990; 54(2):117-21. PubMed ID: 2179754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tip lesion variant of primary focal and segmental glomerulosclerosis: clinicopathological analysis of 20 cases.
    Mungan S; Turkmen E; Aydin MC; Saglam AE; Baydar DE
    Ren Fail; 2015 Jun; 37(5):858-65. PubMed ID: 25857429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
    Dumoulin A; Hill GS; Montseny JJ; Meyrier A
    Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Idiopathic nephrotic syndrome in children: report of 57 cases].
    Ghedira-Besbes L; Mallek A; Guediche MN
    Tunis Med; 2003 Sep; 81(9):702-8. PubMed ID: 17722782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current trends in the treatment of primary glomerulonephritis].
    Ponticelli C; Passerini P
    Minerva Urol Nefrol; 1984; 36(4 Suppl):7-13. PubMed ID: 6398922
    [No Abstract]   [Full Text] [Related]  

  • 11. Focal sclerosing glomerulonephritis.
    Habib R; Gubler MC
    Perspect Nephrol Hypertens; 1973; 1 Pt 1():263-78. PubMed ID: 4536428
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclosporin therapy for steroid resistant nephrotic focal glomerulosclerosis.
    Windom HH; Fisher M; Neale TJ
    N Z Med J; 1990 Mar; 103(886):125-6. PubMed ID: 2320338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indomethacin treatment of recurrent nephrotic syndrome and focal segmental glomerulosclerosis after renal transplantation.
    Kooijmans-Coutinho MF; Tegzess AM; Bruijn JA; Florijn KW; van Es LA; van der Woude FJ
    Nephrol Dial Transplant; 1993; 8(5):469-73. PubMed ID: 8393556
    [No Abstract]   [Full Text] [Related]  

  • 14. [Corticosteroid therapy of compensated intracapillary glomerulonephritis].
    Ratner MIa; Tomilina NA; Samokhina NM
    Klin Med (Mosk); 1982 Apr; 60(4):72-6. PubMed ID: 7098396
    [No Abstract]   [Full Text] [Related]  

  • 15. Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum.
    Stokes MB; Markowitz GS; Lin J; Valeri AM; D'Agati VD
    Kidney Int; 2004 May; 65(5):1690-702. PubMed ID: 15086908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of childhood prednisone-resistant nephrotic syndrome and focal segmental glomerulosclerosis with intravenous methylprednisolone and oral alkylating agents.
    Griswold WR; Tune BM; Reznik VM; Vazquez M; Prime DJ; Brock P; Mendoza SA
    Nephron; 1987; 46(1):73-7. PubMed ID: 3600915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nephrotic syndrom with focal and segmental glomerulosclerosis in Dakar: epidemiological and clinicopathological characteristics (about 134 cases)].
    Niang A; Dial C; Ka EF; Lèye A; Pouye A; Ka MM; Mbengue M; Droz D; Diouf B
    Dakar Med; 2008; 53(1):45-51. PubMed ID: 19102117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment and outcome of adult patients with primary focal segmental glomerulosclerosis in five UK renal units.
    Stirling CM; Mathieson P; Boulton-Jones JM; Feehally J; Jayne D; Murray HM; Adu D
    QJM; 2005 Jun; 98(6):443-9. PubMed ID: 15879445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with cyclosporin of patients with idiopathic nephrotic syndrome.
    Meyrier A
    Springer Semin Immunopathol; 1987; 9(4):441-50. PubMed ID: 3324370
    [No Abstract]   [Full Text] [Related]  

  • 20. Response to cyclophosphamide in steroid-resistant focal segmental glomerulosclerosis: a reappraisal.
    Geary DF; Farine M; Thorner P; Baumal R
    Clin Nephrol; 1984 Sep; 22(3):109-13. PubMed ID: 6488594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.